Enzyme Acquires Myso Finance and Expands to Solana in Major 2024 Growth
Enzyme Acquires Myso Finance and Expands to Solana in Major 2024 Growth
🚀 Enzyme's Secret Weapon Revealed
Enzyme Protocol marked significant expansion in 2024 with key developments:
- Acquired Myso Finance, the leading on-chain covered calls protocol
- Invested in Trade Neutral to expand services to Solana ecosystem
- Extended protocol to Arbitrum and integrated GMX
- Launched first Advanced Automated Loops with Stader Labs
- Reached $220M in Assets Under Technology with 1,400+ creations
2025 roadmap focuses on:
- Completing Solana integration
- Expanding to additional networks
- Launching V5 protocol update
- Strengthening global infrastructure position
The protocol has maintained steady growth since its 2017 launch as Melon Protocol, navigating market cycles while expanding capabilities.
Last week, we shared a major milestone for Enzyme: our investment in @TradeNeutral to bring our services to @solana Why is this important for Enzyme, Decentralized Finance, and Solana? Let’s break down the details⬇️
Network compatibility is essential for the widespread adoption of on-chain asset management services. Enzyme is already available on @ethereum, @0xPolygon, and has recently integrated @arbitrum. But that’s not all! Stay tuned for an exciting announcement this Wednesday🚀
Yesterday, we announced that Enzyme, the leading on-chain asset management infrastructure, is extending its services to @solana through a strategic partnership with @TradeNeutral. What’s next, and why does it matter? Let’s dive in 🧵
ENZYME - NOV 24 RECAP As December sets the stage for an exciting 2025, November proved to be an exhilarating month for Enzyme. @solana expansion, @pendle_fi PTBTC Vault, @staderlabs' Hyperloop on @Swissborg ... — Let’s take a moment to look back and reflect on these milestones.
ICYMI: today’s big news — Enzyme arrives on @Solana, unlocking new DeFi opportunities! Excited to be working together with our friends at @TradeNeutral to make this happen!
We are delighted to share that Enzyme, the leading on-chain asset management infrastructure, has invested in @TradeNeutral and extends its services to @solana! This partnership marks a pivotal moment for Decentralized Finance and the Solana ecosystem. Learn more ⬇️
We are delighted to share that Enzyme, the leading on-chain asset management infrastructure, has invested in @TradeNeutral and extends its services to @solana! This partnership marks a pivotal moment for Decentralized Finance and the Solana ecosystem. Learn more ⬇️
2025 : A NEW CHAPTER 🚀 As we wrap up 2024 and prepare for what promises to be the most pivotal year in Enzyme’s journey, we reflect on the exhilarating path we’ve traveled. In 2025, Enzyme steps into a new chapter, building on past successes to aim higher ⬇️ This milestone
Institutional Treasury Management Hits $100B Milestone
On-chain crypto treasuries have reached a significant milestone with **$100 billion in assets** now being managed by institutional-grade firms, according to Cointelegraph. This signals a fundamental shift in treasury management practices, driven by: - Growing institutional demand for transparency - Need for compliance and risk controls - Adoption of tokenized vaults - Implementation of programmable strategies The trend highlights how treasury management has evolved into a strategic imperative for corporates, DAOs, and asset managers. As more organizations move their operations on-chain, the demand for secure, modular, and transparent asset management infrastructure continues to grow.
Enzyme.Myso Introduces Institutional-Grade Options for On-Chain Yield Generation
Enzyme.Myso is advancing DeFi with institutional-grade on-chain options trading. The platform offers: - Native on-chain options strategies - Fully auditable transaction flows - Infrastructure designed for DAOs and institutions **Real-world implementation**: Compound DAO recently integrated covered calls into their treasury strategy using Enzyme.Myso, targeting approximately 15% APY while maintaining controlled risk exposure. This development signals a shift in how DAOs can optimize idle capital through sophisticated options strategies. *Learn more at* [Enzyme Finance](http://enzyme.finance/products/myso)
Tokenized Securities Market Projected to Reach $45T by 2030
Major financial institutions are forecasting significant growth in tokenized assets: - Citi projects tokenized securities market could reach $45T by 2030 - WEF estimates 10% of global GDP could be blockchain-tokenized by 2027 - McKinsey reports shift from pilot to at-scale deployment Key trends expected in next cycle: - Shift to natively tokenized funds - Increased institutional adoption - Integration with DeFi infrastructure - Clearer regulatory framework Traditional finance faces challenges from outdated systems, while tokenized vehicles offer programmability and global accessibility. Enzyme Protocol is positioning to support this transition with native tokenization capabilities. [Learn more about tokenized funds](http://enzyme.finance/use-cases/tokenized-funds)
Tokenized Real-World Assets Hit Major Milestone
Real-world assets (RWAs) tokenized on blockchain have reached a significant milestone, surpassing $10B in Total Value Locked (TVL). This marks a crucial shift in how traditional assets are being brought on-chain. Key developments: - Over $18B in assets now tokenized (excluding stablecoins) - Infrastructure development becoming priority for operational use - Integration possibilities include RWA funds, ETPs, and indices Enzyme Protocol enables users to leverage these tokenized assets within investment strategies, marking a practical step toward mainstream RWA adoption. Learn more about tokenized asset infrastructure: [Chainlink's Guide](https://blog.chain.link/definitive-guide-to-tokenized-assets/)